Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

SCREENING OF METHANOLIC EXTRACT OF CUSCUTA REFLEXA ROXB . ON STZNICOTINAMIDE INDUCED DIABETIC NEUROPATHY ACTIVITY IN RATS

Abhinav Kumar Shukla*, Vijeta Rajoriya, Dr. Alok Pal Jain

RKDF Collage of Pharmacy, NH-12, Hoshangabad Road, Bhopal (M.P.), 462047

ABSTRACT

Neuropathy, is a secondary complication of diabetes mellitus, is generally considered to be related to duration and severity of hyperglycemia. If the blood glucose level is greater than 250mg/dl than it may be cause secondary complication. The main cause of diabetic neuropathy is hyperglycemia. The aim of treatment of diabetic neuropathy should be treatment of diabetic mellitus and followed by prevention of other side effect. Cuscuta reflexa is known to contain a number of α-glucosidase inhibitory compounds. Cuscuta reflexa is well established drug for diabetic mellitus. Preliminary phytochemical studies of the extract were done according to the published standard methods. Phytochemical analysis revealed the presence of Alkaloids, Glycosides, phytosterols and Triterpenoids, Phenolic and Tannins, flavonoids Methanolic extract of Cucuta reflexa were showed significant effect of body weight, because weight gain is the main side effect of anti-diabetic drugs The significant hyperglycemic activity of methanolic extract of Cucuta reflex at dose of 200mg/kg as compare to 100mg/kg lowered hyperglycemic and it may be useful for the treatment of diabetic and associated complication Significant increase in pain threshold was observed in diabetic animals treated only with negative control. Methanolic extract of Cuscuta reflexa was showed significant effect on thermal pain sensitivity.

Keywords: Cuscuta reflexa Roxb, Methanolic Extract, Nicotinamide, streptozotocin, Diabetic Neuropathy activity.


[Full Text Article]